Serum pepsinogen assay is not recommended for the diagnosis of esophageal squamous cell carcinoma: a systematic review and meta-analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.v68.630207593
   PubMed Web of Science ®Google Scholar
• Baba Y, Iwatsuki M, Yoshida N, Watanabe M, Baba H. Review of the gut microbiome and esophageal cancer: pathogenesis and potential clinical implications. Ann Gastroenterol Surg. 2017;1(2):99–104. doi:10.1002/ags3.1201429863142
   PubMed Web of Science ®Google Scholar
• Pakzad R, Mohammadian-Hafshejani A, Khosravi B, et al. The incidence and mortality of esophageal cancer and their relationship to development in Asia. Ann Transl Med. 2016;4(2):29. doi:10.21037/atm.2016.04.0526889482
   PubMed Web of Science ®Google Scholar
• Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–387. doi:10.1136/gutjnl-2014-30812425320104
   PubMed Web of Science ®Google Scholar
• Gupta B, Kumar N. Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev. 2017;26(2):107–118. doi:10.1097/CEJ.000000000000024927014938
   PubMed Web of Science ®Google Scholar
• Tong Q, Wang XL, Li SB, et al. Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips. Onco Targets Ther. 2018;11:5777–5787. doi:10.2147/OTT.S17124230254470
   PubMed Web of Science ®Google Scholar
• Wei W, Zhang W, Li C, et al. Label-free detection of pepsinogen 1 and 2 by polyethylene coating Lamb microfluidic device. Biosens Bioelectron 2019;129:231–237. doi:10.1016/j.bios.2018.09.075
   Google Scholar
• Samloff IM, Taggart RT. Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med. 1987;10(3):215–221. 3113799
   PubMed Web of Science ®Google Scholar
• Murphy G, Kamangar F, Albanes D, et al. Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut. 2012;61(11):1533–1537. doi:10.1136/gutjnl-2011-30065322180062
   PubMed Web of Science ®Google Scholar
• Park CH, Kim EH, Jung DH, et al. The new modified ABCD method for gastric neoplasm screening. Gastric Cancer. 2016;19(1):128–135. doi:10.1007/s10120-015-0473-425663259
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b265119622551
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-0000922007046
   PubMed Web of Science ®Google Scholar
• Sano H, Tomita K, Sano A, et al. Accuracy of objective tests for diagnosing adult asthma in symptomatic patients: a systematic literature review and hierarchical Bayesian latent-class meta-analysis. Allergol Int 2019;68(2):191–198. doi:10.1016/j.alit.2018.08.013
   Google Scholar
• Peng J, Qi S, Wang P, Li W, Liu C, Li F. Diagnosis and prognostic significance of c-Met in cervical cancer: a meta-analysis. Dis Markers. 2016;2016:6594016. doi:10.1155/2016/659401627069297
   PubMed Web of Science ®Google Scholar
• Wang M, Yang Y, Xu J, Bai W, Ren X, Wu H. CircRNAs as biomarkers of cancer: a meta-analysis. BMC Cancer. 2018;18(1):303. doi:10.1186/s12885-018-4242-829554887
   PubMedGoogle Scholar
• Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther. 2007;26(6):879–887. doi:10.1111/j.1365-2036.2007.03430.x17767472
   PubMed Web of Science ®Google Scholar
• Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut. 2008;57(6):734–739. doi:10.1136/gut.2007.13266218025067
   PubMed Web of Science ®Google Scholar
• Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96(5):388–396. doi:10.1093/jnci/djh05714996860
   PubMedGoogle Scholar
• Kamangar F, Diaw L, Wei WQ, et al. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer. 2009;124(2):456–460. doi:10.1002/ijc.2391818844222
   PubMed Web of Science ®Google Scholar
• Yu G, Gail MH, Shi J, et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev. 2014;23(5):735–741. doi:10.1158/1055-9965.EPI-13-085524700175
   PubMed Web of Science ®Google Scholar
• Gritti I, Banfi G, Roi GS. Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res. 2000;41(3):265–281. doi:10.1006/phrs.1999.058610675278
   PubMed Web of Science ®Google Scholar
• Zwiers A, Crusius B, Pals G, Donker AJ, Meuwissen SG, Ten KR. Human pepsinogen A isozymogen patterns in serum and gastric mucosa. Gastroenterology. 1990;99(6):1576–1580. 2227273
   PubMed Web of Science ®Google Scholar
• Korstanje A, Den Hartog G, Biemond I, Lamers CB. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl. 2002;236:22–26.
   Google Scholar
• Albillos A, Alvarez-Mon M, Rossi I, Gonzalo MA, Marin MC, Abreu L. Different HCl and pepsinogen I secretion patterns in anatomically defined gastric ulcer subsets. Am J Gastroenterol. 1990;85(5):535–538. 2337056
   PubMed Web of Science ®Google Scholar
• Daugule I, Sudraba A, Chiu HM, et al. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol. 2011;23(4):302–307. doi:10.1097/MEG.0b013e3283438ac321389862
   PubMed Web of Science ®Google Scholar
• Rakic S, Dunjic MS, Pesko P, Milicevic M. Atrophic chronic gastritis in patients with epidermoid carcinoma of the esophagus. J Clin Gastroenterol. 1993;17(1):84. doi:10.1097/00004836-199307000-00020
   PubMed Web of Science ®Google Scholar
• Akiyama T, Inamori M, Iida H, et al. Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan. Bmc Gastroenterol. 2009;9:34. doi:10.1186/1471-230X-9-3419450276
   PubMed Web of Science ®Google Scholar
• Sadjadi A, Yazdanbod A, Lee YY, et al. Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. Plos One. 2013;8(9):e74440. doi:10.1371/journal.pone.007444024098650
   PubMed Web of Science ®Google Scholar
• Mwachiro MM, Burgert SL, Lando J, et al. Esophageal squamous dysplasia is common in asymptomatic kenyans: a prospective, community-based, cross-sectional study. Am J Gastroenterol. 2016;111(4):500–507. doi:10.1038/ajg.2016.2626902228
   PubMed Web of Science ®Google Scholar
• Iijima K, Koike T, Abe Y, et al. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol. 2007;102(8):1603–1609. doi:10.1111/j.1572-0241.2007.01257.x17488251
   PubMed Web of Science ®Google Scholar
• Iijima K, Koike T, Abe Y, et al. Gastric hyposecretion in esophageal squamous-cell carcinomas. Dig Dis Sci. 2010;55(5):1349–1355. doi:10.1007/s10620-009-0853-x19513836
   PubMed Web of Science ®Google Scholar
• Nasrollahzadeh D, Malekzadeh R, Aghcheli K, et al. Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit. Br J Cancer. 2012;107(5):888–894. doi:10.1038/bjc.2012.33222814581
   PubMed Web of Science ®Google Scholar
• Cook MB, Dawsey SM, Diaw L, et al. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1966–1975. doi:10.1158/1055-9965.EPI-10-027020647397
   PubMed Web of Science ®Google Scholar
• Ren JS, Kamangar F, Qiao YL, et al. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut. 2009;58(5):636–642. doi:10.1136/gut.2008.16864119136509
   PubMed Web of Science ®Google Scholar
• de Vries AC, Capelle LG, Looman CW, et al. Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes. Int J Cancer. 2009;124(9):2135–2138. doi:10.1002/ijc.2395519107937
   PubMed Web of Science ®Google Scholar
• Xue L, Xing L, Wang J, et al. Serum pepsinogens and Helicobacter pylori are not associated with esophageal squamous cell carcinoma in a high-risk area in China. Tumori. 2013;99(2):134–138. doi:10.1700/1283.1418123748803
   PubMed Web of Science ®Google Scholar
• Venerito M, Kohrs S, Wex T, et al. Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study. Eur J Gastroenterol Hepatol. 2011;23(10):859–864. doi:10.1097/MEG.0b013e328349646921811162
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Omori T, Yokoyama T, et al. Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma. Alcohol Clin Exp Res. 2009;33(5):898–905. doi:10.1111/j.1530-0277.2009.00908.x19320631
   PubMed Web of Science ®Google Scholar